-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Idarubicin is an anthracycline-based chemotherapy drug that is commonly used to treat varioustypes of cancer, including leukemia and lymphoma.
It is a trade name for the drug, the active ingredient isIdarubicin hydrochloride.
The drug is manufactured by various pharmaceutical companies worldwide and is available as aninjectable medication.
Idarubicin works by interfering with the growth and division of cancer cells.
It does this by binding to DNA andpreventing it from being replicated.
This leads to the death of the cancer cells, which in turn slows down the growth of the cancer.
Idarubicin is usually administered intravenously, often in combination with other chemotherapy drugs.
The drug is typically used to treat cancer that has spread to other parts of the body (metastatic cancer) or cancer thathas not responded to other treatments.
It is also used as a main treatment for acute myeloid leukemia (AML) and forchronic myeloid leukemia (CML) in certain cases.
Before taking Idarubicin, patients should inform their doctor about any allergies they may have, any othermedications they are currently taking, and any health conditions they may have, such as heart disease, liver or kidneyproblems.
Pregnant women should also inform their doctor before taking this medication, as it may harm the developing fetus.
Patients receiving Idarubicin may experience side effects such as nausea, vomiting, diarrhea, and hair loss.
These sideeffects are usually temporary and will go away after treatment is completed.
More serious side effects, such as damage to thelung tissue or heart muscle, may also occur.
These side effects are less common, but can be serious.
Patients should informtheir doctor immediately if they experience any unusual symptoms while taking Idarubicin.
In conclusion, Idarubicin is an effective chemotherapy drug that is used to treat different types of cancer.
It works bybinding to DNA and preventing it from being replicated, leading to the death of cancer cells.
It is available as an injectablemedication, and is usually administered intravenously in combination with other chemotherapy drugs.
Patients should inform their doctorabout any allergies, health conditions, or other medications they may be taking before taking Idarubicin.
While it is generally safeand effective, patients may experience side effects, and serious side effects can occur in some cases.
It is important for patients to adhere totheir doctor's instructions and report any unusual symptoms promptly.
With proper use, Idarubicin can be an effective treatment optionfor cancer patients.